Influence of 5-HTTLPR polymorphism on postpartum depressive and posttraumatic symptoms

Area of Science:

• Genetics
• Psychiatry
• Perinatal Health

Background:

• Postpartum depression (PPD) is a complex condition influenced by genetic, psychological, and social factors.
• The 5-HTTLPR polymorphism in the serotonin transporter gene is implicated in PPD onset.
• Understanding genetic predispositions is crucial for targeted interventions.

Purpose of the Study:

• To investigate the impact of 5-HTTLPR polymorphism on prenatal and postnatal depression and PTSD symptoms.
• To identify specific genotypes associated with increased vulnerability to maternal mental health issues.

Main Methods:

• A longitudinal study design with 141 women across three time points: late gestation, 2-3 weeks postpartum, and 3 months postpartum.
• Psychological assessments included the Beck Depression Inventory (BDI), Los Angeles Symptoms Checklist (LASC), Edinburgh Postnatal Depression Scale (EDPS), and Perinatal Posttraumatic Stress Disorder Questionnaire (PPQ).
• Genetic analysis was performed via blood sampling to determine 5-HTTLPR genotypes; statistical analyses included ANOVA and moderation analysis.

Main Results:

• The SS genotype was found to moderate the onset of depressive symptoms at both early and later postpartum stages (T2 and T3).
• This genotype also showed a correlation, direct or indirect, with postpartum PTSD symptoms, including re-experiencing, avoidance, and hyperarousal.
• LL/LS genotypes served as a comparison group for the observed effects of the SS genotype.

Conclusions:

• A lower expression of the serotonin transporter gene, associated with the SS genotype, appears to increase women's susceptibility to postpartum depression and PTSD.
• These findings underscore the role of genetic factors in maternal mental health outcomes.
• The study suggests potential for genetic screening to identify at-risk individuals for enhanced perinatal mental healthcare.